Quetiapine

This classification denotes a serotonin antagonist and antipsychotic agent with the molecular formula C21H25N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BGL0JSY5SI, chemically known as 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol fumarate ( but generally known as quetiapine, which bears US NIH Compound Identifier 5002. European Medicines Agency schedules Quetiapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10192MIG. The term QUETIAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules quetiapine in its Anatomical Therapeutic Chemical (ATC) Classification. QUETIAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quetiapine under HS 29349990 and SITC 51579. As of Q4 2014, QUETIAPINE remains the US FDA Preferred Term for this commodity. Quetiapine bears US NLM identifiers UMLS ID C0123091 and NCI Concept Code C61917. SMILES: S1C2C(C(=NC3C1CCCC3)N1CCN(CC1)CCOCCO)CCCC2.